Noom offers compounded semaglutide and tirzepatide injections and a semaglutide microdose, plus branded drugs like Ozempic, Mounjaro, Wegovy, and Zepbound
In December 2025, the Food and Drug Administration (FDA) approved an oral pill form of Wegovy for weight loss, and in April 2026 approved the once-daily oral GLP-1 drug Foundayo (orforglipron) also for weight loss
Fact : In July 2023, the European Medicines Agency began reviewing reports of patients causing self-harm or having suicidal ideation after taking weight-loss drugs that contain semaglutide
Clinical studies prove that taking diet supplements, with a high content of L-carnitine, in a comprehensive way protects the proper functioning of the cardiovascular system
SandMan Complex: A proprietary botanical blend designed to support GABA activity, calm the nervous system, and promote deep relaxation without stimulation